glp-1 obesity drug news A network meta-analysis backed weight-loss benefits with several receptor agonists, with less certainty for newer-generation agents. Read more at the link in bio World Health Organization recommends GLP-1
Description
21,22 Although clear protective benefits in diabetic retinopathy development and impact on disease progression remain under investigation, GLP-1RAs have been shown to reduce complications from chronic diabetes, such as retinal vein occlusion and cardiovascular disease
E.AhreB
Chris Serres: What the medications do is they produce this natural hormone, in the gut
As the disease progresses, scar tissue builds in the liver, eventually impairing its ability to function
[DOI] [PMC free article] [PubMed] [Google Scholar] 84.Wang J., Liao B., Wang C., Zhong O., Lei X., Yang Y
